Bloomberg News

Teva Says U.S. FDA Approves Aerosol Treatment of Nasal Allergies

March 26, 2012

Teva Pharmaceutical Industries Ltd. (TEVA) said the U.S. Food and Drug Administration has approved its QNASL nasal aerosol for the treatment of nasal allergies. The product will be available by prescription in April 2012, Teva said in a Business Wire statement today.

To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at ssolomon22@bloomberg.net

To contact the editor responsible for this story: Gwen Ackerman at gackerman@bloomberg.net


The Good Business Issue
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus